Synchronous telemetry transmission between a programmer and an autonomous device
First Claim
1. A system comprising:
- an active implanted medical device;
a programmer for said active implanted medical device; and
a bi-directional synchronous serial connection for signals passing between the active implanted medical device and the programmer;
the active implanted medical device (10) further comprising a timing clock having a frequency (18) and means for emitting a telemetry signal to pass to the programmer and for receiving a telemetry signal passing from the programmer, said means operating under a temporal control of the active implanted medical device timing clock;
the programmer (24) further comprising a programmable timing clock (42) having a frequency that is adjustable in phase, means for emitting a telemetry signal to pass to the active implanted medical device and for receiving a telemetry signal passing from the active implanted medical device, said means operating under the temporal control of the programmer timing clock, a means of synchronization control (32, 36, 38,
40) cooperating with said programmable clock for analyzing a telemetry signal received from the active implanted medical device and to lock in phase the programmable clock on the active implanted medical device timing clock.
2 Assignments
0 Petitions

Accused Products

Abstract
An active implanted medical device, particularly an active implantable medical device, and its external programmer having a bi-directional synchronous transmission of data. The active implanted medical device (10) includes a timing clock (18) and circuits for the emission/reception of signals operating under the temporal control of the timing clock of the active implanted medical device. The programmer (24) includes a timing clock (42) and circuits for the emission/reception of signals, operating under the temporal control of the programmer timing clock. The device (10) and programmer (24) exchange data there-between using a bi-directional synchronous serial connection, in which the programmer timing clock (42) is a programmable clock, adjustable in phase, and the programmer has a synchronization control circuit (32, 36, 38, 40) cooperating with its programmable timing clock, to analyze a signal received from the active implanted medical device and to lock in phase the programmer programmable timing clock on the timing clock of the active implanted medical device.
210 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
OPTIMIZATION OF TIMING FOR DATA COLLECTION AND ANALYSIS IN ADVANCED PATIENT MANAGEMENT SYSTEM | ||
Patent #
US 20110071848A1
Filed 11/29/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Robert J. Sweeney
|
System and method for managing a data transmission layer for a personal medical device | ||
Patent #
US 7,894,476 B2
Filed 06/16/2008
|
Current Assignee
Biotronik SE Company KG
|
Original Assignee
Biotronik VI Patent AG
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Tactile feedback for indicating validity of communication link with an implantable medical device | ||
Patent #
US 7,934,508 B2
Filed 01/08/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Wireless ECG system | ||
Patent #
US 7,933,642 B2
Filed 05/16/2003
|
Current Assignee
LifeSync Corporation
|
Original Assignee
LifeSync Corporation
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
DRUG DELIVERY WITH EVENT NOTIFICATION | ||
Patent #
US 20110184343A1
Filed 03/30/2011
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
DELIVERY DEVICE FOR IMPLANTABLE MONITOR | ||
Patent #
US 20110230866A1
Filed 03/16/2010
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Given Imaging Limited
|
Optimization of timing for data collection and analysis in advanced patient management system | ||
Patent #
US 8,055,517 B2
Filed 11/29/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Fail-safe programming for implantable medical device | ||
Patent #
US 8,068,917 B2
Filed 08/29/2003
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Drug delivery pen with event notification means | ||
Patent #
US 7,713,229 B2
Filed 11/05/2004
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Advanced patient management system including interrogator/transceiver unit | ||
Patent #
US 7,751,901 B2
Filed 10/26/2005
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
DRUG DELIVERY WITH EVENT NOTIFICATION | ||
Patent #
US 20100168661A1
Filed 03/12/2010
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Optimization of timing for data collection and analysis in advanced patient management system | ||
Patent #
US 7,752,059 B2
Filed 07/05/2005
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Tactile feedback for indicating validity of communication link with an implantable medical device | ||
Patent #
US 7,699,060 B2
Filed 10/26/2004
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
TACTILE FEEDBACK FOR INDICATING VALIDITY OF COMMUNICATION LINK WITH AN IMPLANTABLE MEDICAL DEVICE | ||
Patent #
US 20100114251A1
Filed 01/08/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Prosthetic intervertebral spinal disc with integral microprocessor | ||
Patent #
US 7,794,499 B2
Filed 06/08/2004
|
Current Assignee
Theken Spine LLC
|
Original Assignee
Theken Disc LLC
|
Repeater providing data exchange with a medical device for remote patient care and method thereof | ||
Patent #
US 7,791,467 B2
Filed 10/16/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
OPTIMIZATION OF TIMING FOR DATA COLLECTION AND ANALYSIS IN ADVANCED PATIENT MANAGEMENT SYSTEM | ||
Patent #
US 20100250287A1
Filed 06/08/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Robert J. Sweeney
|
ADAPTIVE SOFTWARE CONFIGURATION FOR A MEDICAL DEVICE | ||
Patent #
US 20100049279A1
Filed 10/26/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Jeffrey M Thompson, Par Lindh, James Kalgren, Scott Vanderlinde, John A. Dyjach, Michael Seeberger, Kristine M. Larsen-Kelly, Mitchell Lanz
|
Repeater Providing Data Exchange with a Medical Device for Remote Patient Care and Method Thereof | ||
Patent #
US 20100328062A1
Filed 09/02/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Optimization of timing for data collection and analysis in advanced patient management system | ||
Patent #
US 7,860,733 B2
Filed 06/08/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Radiolucent chest assembly | ||
Patent #
US 7,860,557 B2
Filed 04/13/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
LifeSync Corporation
|
SYSTEM AND METHOD FOR MANAGING A DATA TRANSMISSION LAYER FOR A PERSONAL MEDICAL DEVICE | ||
Patent #
US 20090028185A1
Filed 06/16/2008
|
Current Assignee
Biotronik SE Company KG
|
Original Assignee
Biotronik VI Patent AG
|
REMOTELY PROGRAMMABLE PERSONAL DEVICE AND SYSTEM AND METHOD FOR REMOTE PROGRAMMING OF A PERSONAL DEVICE | ||
Patent #
US 20090043353A1
Filed 07/07/2008
|
Current Assignee
Biotronik SE Company KG
|
Original Assignee
Biotronik VI Patent AG
|
Assessing Noise on a Communication Channel | ||
Patent #
US 20090110131A1
Filed 08/26/2008
|
Current Assignee
Data Sciences U K Limited
|
Original Assignee
Transoma Medical Inc.
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 7,624,293 B2
Filed 02/15/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Adaptive software configuration for a medical device | ||
Patent #
US 7,630,773 B2
Filed 11/16/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 7,321,837 B2
Filed 02/15/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
DELIVERY DEVICE FOR IMPLANTABLE MONITOR | ||
Patent #
US 20080091177A1
Filed 04/25/2007
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Medtronic Incorporated
|
Wireless ECG system | ||
Patent #
US 7,403,808 B2
Filed 03/11/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
LifeSync Corporation
|
Implantable medical device having long-term wireless capabilities | ||
Patent #
US 7,395,117 B2
Filed 12/23/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Frame length modulation and pulse position modulation system | ||
Patent #
US 7,418,297 B2
Filed 07/28/2005
|
Current Assignee
Data Sciences U K Limited
|
Original Assignee
Transoma Medical Inc.
|
Implantable medical device having long-term wireless capabilities | ||
Patent #
US 20080211665A1
Filed 05/06/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Programmable wireless electrode system for medical monitoring | ||
Patent #
US 7,171,166 B2
Filed 10/21/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
Motorola Inc.
|
Optimization of timing for data collection and analysis in advanced patient management system | ||
Patent #
US 20070011028A1
Filed 07/05/2005
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Adaptive software configuration for a medical device | ||
Patent #
US 7,167,755 B2
Filed 10/05/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Wireless ECG system | ||
Patent #
US 7,197,357 B2
Filed 11/30/2001
|
Current Assignee
LifeSync Corporation
|
Original Assignee
LIFE SYNC CORPORATION
|
METHOD AND APPARATUS FOR ENABLING DATA COMMUNICATION BETWEEN AN IMPLANTABLE MEDICAL DEVICE AND A PATIENT MANAGEMENT SYSTEM | ||
Patent #
US 20070083246A1
Filed 10/03/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Wireless medical diagnosis and monitoring equipment | ||
Patent #
US 7,215,991 B2
Filed 03/24/2003
|
Current Assignee
Body Science LLC
|
Original Assignee
Motorola Inc.
|
Bluetooth association based on docking connection | ||
Patent #
US 7,249,212 B2
Filed 12/22/2004
|
Current Assignee
Toshiba Global Commerce Solutions Holdings Corporation
|
Original Assignee
International Business Machines Corporation
|
Wireless electrocardiograph system and method | ||
Patent #
US 7,272,428 B2
Filed 05/16/2003
|
Current Assignee
LifeSync Corporation
|
Original Assignee
Motorola Inc.
|
Repeater device for communications with an implantable medical device | ||
Patent #
US 7,292,139 B2
Filed 01/09/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Programmable wireless electrode system for medical monitoring | ||
Patent #
US 6,987,965 B2
Filed 10/22/2002
|
Current Assignee
LifeSync Corporation
|
Original Assignee
Motorola Inc.
|
Repeater device for communications with an implantable medical device | ||
Patent #
US 7,009,511 B2
Filed 12/17/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Systems and methods for drug therapy enhancement using expected pharmacodynamic models | ||
Patent #
US 20060089592A1
Filed 10/21/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Integrated pharmaceutical dispensing and patient management monitoring | ||
Patent #
US 20060089856A1
Filed 10/21/2004
|
Current Assignee
Cardiac Pacemakers
|
Original Assignee
Cardiac Pacemakers
|
Advanced patient management system including interrogator/transceiver unit | ||
Patent #
US 20060106433A1
Filed 10/26/2005
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Programmable device for an implant comprising a base station and a detachable hand set | ||
Patent #
US 20060100673A1
Filed 08/28/2003
|
Current Assignee
Biotronik SE Company KG
|
Original Assignee
Klaus Brandau, Michael Koinzer, Bernhard Gromotka
|
Bluetooth association with simple power connection | ||
Patent #
US 20060136647A1
Filed 12/22/2004
|
Current Assignee
Toshiba Global Commerce Solutions Holdings Corporation
|
Original Assignee
International Business Machines Corporation
|
Bluetooth association based on docking connection | ||
Patent #
US 20060136646A1
Filed 12/22/2004
|
Current Assignee
Toshiba Global Commerce Solutions Holdings Corporation
|
Original Assignee
International Business Machines Corporation
|
Repeater device for communications with an implantable medical device | ||
Patent #
US 20060121846A1
Filed 01/09/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Scott T. Mazar, Yatheendhar D. Manicka
|
Device communications of an implantable medical device and an external system | ||
Patent #
US 7,065,409 B2
Filed 12/13/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 20060155495A1
Filed 02/15/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 20060161384A1
Filed 02/15/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 7,079,977 B2
Filed 10/15/2003
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Ambulatory medical apparatus with hand held communication device | ||
Patent #
US 20060173444A1
Filed 02/03/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Method and apparatus for enabling data communication between an implantable medical device and a patient management system | ||
Patent #
US 7,127,300 B2
Filed 12/23/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Telemetry head programmer for implantable medical device and system and method | ||
Patent #
US 20060247710A1
Filed 04/29/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Bluetooth association with simple power connection | ||
Patent #
US 7,146,449 B2
Filed 12/22/2004
|
Current Assignee
Toshiba Global Commerce Solutions Holdings Corporation
|
Original Assignee
International Business Machines Corporation
|
Fail-safe programming for implantable medical device | ||
Patent #
US 20050049656A1
Filed 08/29/2003
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Telemetry apparatus and method for an implantable medical device | ||
Patent #
US 20050055068A1
Filed 07/19/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Tactile feedback for indicating validity of communication link with an implantable medical device | ||
Patent #
US 20050085703A1
Filed 10/26/2004
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Wireless system protocol for telemetry monitoring | ||
Patent #
US 6,897,788 B2
Filed 04/17/2002
|
Current Assignee
LifeSync Corporation
|
Original Assignee
Motorola Inc.
|
Large-scale processing loop for implantable medical devices | ||
Patent #
US 6,920,360 B2
Filed 12/18/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Wireless ECG system | ||
Patent #
US 20050177052A1
Filed 03/11/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
GMP Wireless Medicine Incorporated
|
Frame length modulation and pulse position modulation for telemetry of analog and digital data | ||
Patent #
US 6,947,795 B2
Filed 10/01/2001
|
Current Assignee
Data Sciences U K Limited
|
Original Assignee
Transoma Medical Inc.
|
Telemetry apparatus and method for an implantable medical device | ||
Patent #
US 6,954,673 B2
Filed 07/19/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Large-scale processing loop for implantable medical devices | ||
Patent #
US 20050240246A1
Filed 04/14/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Vital signs monitoring assembly having elastomeric connectors | ||
Patent #
US 20050251002A1
Filed 04/13/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
GMP Wireless Medicine Incorporated
|
Radiolucent chest assembly | ||
Patent #
US 20050251004A1
Filed 04/13/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
GMP Wireless Medicine Incorporated
|
Disposable chest assembly | ||
Patent #
US 20050251003A1
Filed 04/13/2005
|
Current Assignee
LifeSync Corporation
|
Original Assignee
GMP Wireless Medicine Incorporated
|
Prosthetic intervertebral spinal disc with integral microprocessor | ||
Patent #
US 20050273170A1
Filed 06/08/2004
|
Current Assignee
Theken Spine LLC
|
Original Assignee
Theken Spine LLC
|
Advanced patient management system including interrogator/transceiver unit | ||
Patent #
US 6,978,182 B2
Filed 12/27/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Implantable monitoring probe | ||
Patent #
US 6,689,056 B1
Filed 04/06/2000
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Medtronic Endonetics Inc.
|
Implantable medical device with hardware-based patch | ||
Patent #
US 20040064165A1
Filed 09/30/2002
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
LV ectopic density trending | ||
Patent #
US 6,718,197 B1
Filed 11/02/2000
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Wireless ECG system | ||
Patent #
US 20040073127A1
Filed 05/16/2003
|
Current Assignee
LifeSync Corporation
|
Original Assignee
GMP Company Limited
|
Cohlear implant communicator | ||
Patent #
US 20040094355A1
Filed 11/10/2003
|
Current Assignee
Cochlear Limited
|
Original Assignee
Cochlear Limited
|
Implantable medical device having long-term wireless capabilities | ||
Patent #
US 20040122489A1
Filed 12/23/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Method and apparatus for enabling data communication between an implantable medical device and a patient management system | ||
Patent #
US 20040122488A1
Filed 12/23/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Device communications of an implantable medical device and an external system | ||
Patent #
US 20040116981A1
Filed 12/13/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Synchronization and calibration of clocks for a medical device and calibrated clock | ||
Patent #
US 20040133390A1
Filed 10/15/2003
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable monitoring probe | ||
Patent #
US 20040133089A1
Filed 10/16/2003
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Endonetics Inc.
|
Telemetry apparatus and method for an implantable medical device | ||
Patent #
US 6,766,201 B2
Filed 06/03/2003
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
System and method for ad hoc communications with an implantable medical device | ||
Patent #
US 20040128161A1
Filed 12/27/2002
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Cochlear implant | ||
Patent #
US 6,778,858 B1
Filed 04/18/2002
|
Current Assignee
Advanced Bionics
|
Original Assignee
Advanced Bionics LLC
|
Implantable monitoring probe | ||
Patent #
US 20040158138A1
Filed 10/16/2003
|
Current Assignee
Endonetics Inc.
|
Original Assignee
Endonetics Inc.
|
Implantable monitoring probe | ||
Patent #
US 20040260164A1
Filed 07/22/2004
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Endonetics Inc.
|
System and method for persistence-vector-based rate assignment | ||
Patent #
US 20030152103A1
Filed 02/20/2003
|
Current Assignee
Qualcomm Inc.
|
Original Assignee
Gadi Karmi, Matthew Stuart Grob, Paul E. Bender
|
Data management of patient medical information for use with an implantable medical device | ||
Patent #
US 20030177031A1
Filed 03/15/2002
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Telemetry apparatus and method for an implantable medical device | ||
Patent #
US 20030195589A1
Filed 06/03/2003
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Tactile feedback for indicating validity of communication link with an implantable medical device | ||
Patent #
US 6,644,321 B1
Filed 10/29/1999
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Patient activated telemetry control unit using bidirectional asymmetric dual-mode telemetry link to communicate with an implanted device | ||
Patent #
US 6,400,990 B1
Filed 02/18/2000
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
System and method for portable implantable device interogation | ||
Patent #
US 6,263,245 B1
Filed 08/12/1999
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Large-scale processing loop for implantable medical devices | ||
Patent #
US 20010039375A1
Filed 12/18/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Medical device programmer with selective disablement of display during telemetry | ||
Patent #
US 20070288068A1
Filed 08/07/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Repeater providing data exchange with a medical device for remote patient care and method thereof | ||
Patent #
US 8,130,093 B2
Filed 09/02/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Systems and methods for drug therapy enhancement using expected pharmacodynamic models | ||
Patent #
US 8,150,509 B2
Filed 10/21/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Delivery device for implantable monitor | ||
Patent #
US 8,219,171 B2
Filed 03/16/2010
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Given Imaging Limited
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Wireless ECG system | ||
Patent #
US 8,255,041 B2
Filed 02/03/2011
|
Current Assignee
LifeSync Corporation
|
Original Assignee
LifeSync Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable monitoring probe | ||
Patent #
US 8,323,192 B2
Filed 07/22/2004
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Endonetics Inc.
|
Optimization of timing for data collection and analysis in advanced patient management system | ||
Patent #
US 8,326,652 B2
Filed 10/28/2011
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Drug delivery with event notification | ||
Patent #
US 8,333,752 B2
Filed 03/12/2010
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Repeater providing data exchange with a medical device for remote patient care and method thereof | ||
Patent #
US 8,451,113 B2
Filed 02/10/2012
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Drug delivery with event notification | ||
Patent #
US 8,551,039 B2
Filed 03/30/2011
|
Current Assignee
LifeScan IP Holdings LLC
|
Original Assignee
Lifescan Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Adaptive software configuration for a medical device | ||
Patent #
US 8,639,346 B2
Filed 10/26/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Telemetry head programmer for implantable medical device and system and method | ||
Patent #
US 8,700,157 B2
Filed 04/29/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable medical device having long-term wireless capabilities | ||
Patent #
US 8,700,172 B2
Filed 05/06/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Wireless medical diagnosis and monitoring equipment | ||
Patent #
US 8,771,184 B2
Filed 05/04/2007
|
Current Assignee
Body Science LLC
|
Original Assignee
Body Science LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method providing data exchange with a medical device for remote patient care | ||
Patent #
US 8,791,815 B2
Filed 04/25/2013
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Remotely programmable personal device and system and method for remote programming of a personal device | ||
Patent #
US 8,855,781 B2
Filed 07/07/2008
|
Current Assignee
Biotronik SE Company KG
|
Original Assignee
Biotronik VI Patent AG
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Assessing noise on a communication channel | ||
Patent #
US 8,996,124 B2
Filed 08/26/2008
|
Current Assignee
Data Sciences U K Limited
|
Original Assignee
Data Sciences U K Limited
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 8,992,475 B2
Filed 02/01/2007
|
Current Assignee
James D. Causey III, Medtronic Minimed Incorporated, Alfred E. Mann, Dennis P. Bishop, Luis J. Malave, Deborah Ruppert, Jay Yonemoto, Alan Haubach, Chad Srisathapat, John Livingston, Bob Murtfeldt, Cliff Hague, Adrian Gut
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for enabling data communication between an implantable medical device and a patient management system | ||
Patent #
US 9,114,265 B2
Filed 10/03/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Medical device programmer with selective disablement of display during telemetry | ||
Patent #
US 9,248,298 B2
Filed 08/07/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 9,415,157 B2
Filed 02/01/2007
|
Current Assignee
James D. Causey III, Medtronic Minimed Incorporated, Alfred E. Mann, Dennis P. Bishop, Luis J. Malave, Deborah Ruppert, Jay Yonemoto, Alan Haubach, Chad Srisathapat, John Livingston, Bob Murtfeldt, Cliff Hague, Adrian Gut
|
Original Assignee
Medtronic Minimed Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Enabling data communication between an implantable medical device and a patient management system | ||
Patent #
US 9,578,449 B2
Filed 08/20/2015
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Delivery device for implantable monitor | ||
Patent #
US 9,675,285 B2
Filed 04/25/2007
|
Current Assignee
Given Imaging Limited
|
Original Assignee
Given Imaging Limited
|
Fail-safe programming for implantable medical device | ||
Patent #
US 9,713,724 B2
Filed 10/20/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 9,744,301 B2
Filed 07/19/2016
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Enabling data communication between an implantable medical device and a patient management system | ||
Patent #
US 9,979,810 B2
Filed 12/28/2016
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities | ||
Patent #
US 10,279,110 B2
Filed 08/27/2017
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Frame synchronization device for a synchronous digital bit stream divided into blocks by means of a block code and structured in frames | ||
Patent #
US 4,943,985 A
Filed 05/17/1989
|
Current Assignee
Societe Anonyme DBA
|
Original Assignee
Societe Anonyme DBA
|
Sample-and-hold digital phase-locked loop for ask signals | ||
Patent #
US 4,947,407 A
Filed 08/08/1989
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
SIEMENS-PACESETTER INC.
|
Method and apparatus for obtaining reliable synchronization over a noisy channel | ||
Patent #
US 4,701,939 A
Filed 04/01/1985
|
Current Assignee
General Electric Company
|
Original Assignee
General Electric Company
|
Embedded data link and protocol | ||
Patent #
US 5,741,314 A
Filed 09/04/1996
|
Current Assignee
Cochlear Limited
|
Original Assignee
Cochlear Limited
|
Method and apparatus for telemetering data bidirectionally between two devices, one device incorporating a coarse phase adjustment and the other device incorporating a fine phase adjustment | ||
Patent #
US 5,769,876 A
Filed 07/02/1996
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
Apparatus and methods for communications with implanted active medical devices | ||
Patent #
US 5,674,265 A
Filed 12/23/1994
|
Current Assignee
Sorin CRM USA
|
Original Assignee
Ela Medical S.A.
|
Method and apparatus for improving the resolution of pulse position modulated communications between an implantable medical device and an external medical device | ||
Patent #
US 5,522,866 A
Filed 11/01/1994
|
Current Assignee
Intermedics Incorporated
|
Original Assignee
Intermedics Incorporated
|
Method and apparatus for synchronization in a wireless telephone system | ||
Patent #
US 5,384,828 A
Filed 10/18/1993
|
Current Assignee
Motorola Inc.
|
Original Assignee
Motorola Inc.
|
Method and apparatus for determining byte synchronization within a serial data receiver | ||
Patent #
US 5,448,571 A
Filed 04/26/1994
|
Current Assignee
Mariana HDD B.V.
|
Original Assignee
International Business Machines Corporation
|
Dual channel telemetry for implanted medical device | ||
Patent #
US 5,314,450 A
Filed 06/10/1992
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Telemetry system for an implantable medical device | ||
Patent #
US 5,354,319 A
Filed 01/29/1993
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Synchronous telemetry receiver and receiving method for an implantable medical device | ||
Patent #
US 5,241,961 A
Filed 05/29/1992
|
Current Assignee
COOK PACEMAKER CORPORATION
|
Original Assignee
COOK PACEMAKER CORPORATION
|
Timing recovery scheme for burst communication systems having a VCO with injection locking circuitry | ||
Patent #
US 4,918,406 A
Filed 04/26/1989
|
Current Assignee
Raytheon Company
|
Original Assignee
Raytheon Company
|
20 Claims
-
1. A system comprising:
-
an active implanted medical device; a programmer for said active implanted medical device; and a bi-directional synchronous serial connection for signals passing between the active implanted medical device and the programmer; the active implanted medical device (10) further comprising a timing clock having a frequency (18) and means for emitting a telemetry signal to pass to the programmer and for receiving a telemetry signal passing from the programmer, said means operating under a temporal control of the active implanted medical device timing clock; the programmer (24) further comprising a programmable timing clock (42) having a frequency that is adjustable in phase, means for emitting a telemetry signal to pass to the active implanted medical device and for receiving a telemetry signal passing from the active implanted medical device, said means operating under the temporal control of the programmer timing clock, a means of synchronization control (32, 36, 38,
40) cooperating with said programmable clock for analyzing a telemetry signal received from the active implanted medical device and to lock in phase the programmable clock on the active implanted medical device timing clock. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A method of telemetry between an active implanted medical device and a programmer comprising:
-
providing the active implanted medical device with a timing clock having a first frequency; providing the programmer with a timing clock having a second frequency which is programmable in phase; transmitting a synchronization signal from said active implanted medical device under the control of the active implanted medical device timing clock; detecting the synchronization signal at the programmer; analyzing the detected synchronization signal and determining a difference in phase between said synchronization signal and said second frequency, and adjusting said programmer programmable clock to lock in phase said programmer programmable clock on said active implantable medical device timing clock. - View Dependent Claims (10, 11, 12)
-
-
13. A programmer system having bi-directional synchronous telemetry communications for use with an active implanted medical device having a timing clock and telemetry signals emitted under temporal control of said timing clock, comprising:
-
a programmer head having a coil for receiving a telemetry signal, an analog to digital converter having an analog input corresponding to a received telemetry signal and a digital output corresponding to said analog input, the analog to digital converter having a sample rate control input to control the rate of sampling of the analog signal; a programmable timing clock having an output frequency that is adjustable in phase; means for processing the digital output from said analog to digital converter, determining a difference in phase between the digital output and the programmable timing clock output frequency, and adjusting the phase of the programmable timing clock to lock it in phase with the digital output. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20)
-
1 Specification
The present invention concerns the area of autonomous devices, particularly active implanted medical devices, and more particularly the exchange of data during communication sequences between the autonomous device and an external control console.
Active implanted medical devices comprise particularly cardiac pacemakers, defibrillators, neurological devices, pumps for the delivery of medical substance (so-called diffusion pumps) and cochlear implants. These devices, once put in place, are programmed from the exterior by use of a remote or distant console called a "programmer". The invention, however, is not limited to active implanted medical devices. Indeed, although the invention is described with reference to active implanted medical devices, the invention also applies to medical devices that are not implanted (for example, devices carried by the patient), and to non-active medical devices (for example, devices, whether or not implanted, that are without a source of energy (e.g., a battery) and which use for the emission of signals to the exterior a portion of the energy of an interrogating signal that is applied to the device), and to autonomous devices other than medical devices. The reference to an "implant" in the description is, therefore, not in itself restrictive to implanted medical devices and should be construed synonymous with autonomous device (except when used as an adverb to a medical device).
The verification of parameters of the implant or the transmission of information to be recorded (stored) by the implant is realized by electromagnetic inductive coupling, called "telemetry" in the technique in question. Thus, a programmer communicates with an autonomous device by telemetry.
Each programmer is provided with a receiver head that is placed in face of, that is in the proximity to the site of, the implant. The head comprises a coil (also called an antenna) that collects the magnetic field generated from or by the implanted device. The programmer also is configured to send information to the implant by electromagnetic means. This is typically done by causing a current in the programmer coil to oscillate, which current will provoke a voltage at the output of the reception coil of the implant, and produce a voltage on the implant coil leads. These voltages are collected (sensed) and decoded by the implant.
Signals emitted by the implant are collected by the programmer coil, amplified, filtered, digitized and decoded by the programmer circuits. This allows one to realize a transmission in two directions between the implant and the programmer (i.e., bi-directional telemetry). It is noted that for each of the programmer and the autonomous device, the coil used for receiving signals can also be used to transmit signals, although different coils or different combinations of coils may be used for receiving and sending.
It has been previously proposed to operate data transmission in a synchronous mode between an implant and a programmer. In the known technique, the programmer possesses a clock that defines the rhythm (rate) of data transmission, which rate is imposed on the implant when the implant has data to emit in the direction of the programmer. This technique, if it is able to benefit from the advantages of a synchronous transmission, is nevertheless limited in its possibilities of implementation because it presupposes that the implant is able to measure, establish, and maintain the cadence of the transmission rate imposed by the programmer.
In practice, it is indispensable to limit the transmission rate if this condition is to be satisfied in a quasi-certain manner, independent of the type of implant that is interrogated by the programmer. In others words, it is desirable, if not necessary, to find a compromise between the speed of the synchronous transmission and the security of transmission. Too high a speed will present a risk of losing the synchronism during the transmission, and, therefore, result in the erroneous interpretation by the programmer of the transmitted data.
It is, therefore, an object of the present invention to overcome the aforementioned limitations of the known devices by a new technique of establishing and maintaining the synchronism of the transmission.
It is another object of the invention to allow a bi-directional exchange of data between an implant and a programmer with high speed of transmission and a maximal degree of reliability.
To this end, the invention proposes to establish a serial synchronous transmission between the implant and the programmer and to maintain the synchronism during the whole duration of the exchange of data.
Broadly, the invention proposes, instead of adjusting the data transmission rate by the implant to a frequency imposed by the programmer, to provide the programmer with a programmable clock, adjustable in phase, and to synchronize this programmable clock on the clock of the implant. The implant is then free to emit data at its clock frequency, which will be able to be greater than the frequencies typically used up until now, and the programmer is then synchronized on this implant clock frequency. More preferably, the programmer clock is synchronized to lock on the implant transmission frequency by a periodic adjustment (tuning), realized in real time.
One also will understand that proceeding in this manner allows for simplifying the circuits of the implant, with a correlative lowering of the cost of the implant circuits, such that any increase in the complexity of the circuits is placed on the side of the programmer. In others words, one can increase substantially the technical performance of the implant without increasing the cost of the implant, and perhaps even lower the implant cost.
One aspect of the invention concerns a system including, on the one hand, an autonomous device, particularly an active implantable medical device including a timing clock and a telemetry system that emits signals in direction of the programmer and receives signals issued by the programmer, with the telemetry system operating under the temporal control of the autonomous device timing clock, and, on the other hand, a device that is an external programmer for the autonomous device, including a timing clock and a telemetry system that emits signals in the direction of the autonomous device and receives signals originating from the autonomous device, the programmer telemetry system operating under the temporal control of the programmer timing clock, in which the link of the data exchange between the autonomous device and the programmer is a bi-directional synchronous serial link, the programmer timing clock is a programmable clock, adjustable in phase, and the programmer includes a synchronization control circuit which cooperates with the programmable timing clock to analyze a signal received from the autonomous device and to lock in phase the programmer timing clock on the timing clock of the autonomous device.
Very advantageously, to establish initially the synchronism, the autonomous device emits in direction of the programmer a synchronization signal which is emitted according to the autonomous device timing clock frequency. The programmer receives the synchronization signal, correlates the received signal with a reference pattern, determines a difference, and adjusts the programmer programmable clock by a value corresponding to the determined difference.
The synchronization signal can be preferably emitted by the autonomous device in response to an interrogation signal emitted by the programmer, the interrogation signal being one that is recognizable by the autonomous device even in the absence of any synchronism of the transmission. In one embodiment, the synchronization signal is preferably a periodic signal, and the programmer synchronization control circuit includes a means for averaging the periodic signal before making a correlation with the reference pattern.
Even more advantageously, to maintain the synchronism once it is initially established, the synchronization control circuit of the programmer includes a means to receive a data signal emitted by the autonomous device, to correlate the continuation by periodicity of the data signal received, that is, the repetition of a signal (i.e. a symbol) during successive periodic time intervals, with a reference pattern to determine a temporal difference, and to adjust the programmable clock by a value corresponding to the determined temporal difference.
The programmer synchronization control circuit can be implemented to perform the foregoing functions in any number of ways, for example, by a programmable digital circuit, more particularly a digital signal processor, operating under the control of a software program loaded in a memory. Further, the software control program is preferably a downloadable program so as to be able to modify the program without hardware modification of the programmer. Other aspects of the invention concern a programmer that can be automatically synchronized to an implant having a synchronization signal output, and a method of establishing synchronization between an autonomous device and an implant particularly acting implantable medical device, as will become clear in the following.
Other characteristics and advantages of the present invention will appear to a person of ordinary skill in the art in view of the following detailed description of a process of implementation of the invention, made with reference to the annexed drawings, in which:
FIG. 1 is a block diagram of the implant and the programmer circuits for the reception and processing of signals;
FIG. 2 is a representation of various timings plots illustrating the interest of a synchronous transmission;
FIG. 3 illustrates the risk of error in the interpretation of signals of FIG. 2 in the case of defects in synchronism;
FIG. 4 illustrates the principle of re-synchronization used by the present invention;
FIG. 5 illustrates the mode of synchronous access, in reading and simultaneous writing of a FIFO memory;
FIG. 6 illustrates the dependence between the programmable clock and control signals of an analog/digital converter;
FIGS. 7 and 8 illustrate the steps, implemented in accordance with a preferred embodiment of the process of the invention, of correlation of the synchronization signal with a reference pattern;
FIG. 9 represents, in the temporal reference of the programmer, a suitable analysis made by the programmer for determining the difference between the programmer clock and the implant clock; and
FIG. 10 is a timing diagram presenting the manner in which the bi-directional data exchange, in the form of reference signals, is realized according an embodiment of the invention.
With reference to FIG. 1, the reference 10 designates an "autonomous device" or "implant" in the broad sense defined above, and, in this illustrated example, a medical device implanted in a patient, beneath the cutaneous barrier 12. The implant 10 comprises a housing or case 14 containing various electronic circuits, particularly including a memory storing information that can be transmitted to the exterior, and/or information that can be updated, by a bi-directional "telemetry" transmission. The case 14 circuits are able to generate a varying magnetic induction field that is provoked by the passage of currents oscillating in a coil (antenna) 15 in a manner itself well-known. The implant 10 also includes electronic circuit 16 which operates under the temporal control of an integrated clock 18, which is in turn controlled by an oscillator 20. Signals emitted by the implant 10, that are of essentially of a magnetic nature as explained above, are collected by the receiver head or "programming head" 22 of a programmer 24, that is, for example, a device of a type comparable to that described in EP-A-0 661 077 and its corresponding U.S. patent application Ser. No. 08/363,742, now issued as U.S. Pat. No. 5,674,265, to which one will be able to refer for further details regarding the manner by which these signals are collected or processed, and which U.S. Patent Application is co-pending and commonly assigned and incorporated herein by reference in its entirety. The head 22 also can operate as an emitter for the transmission of signals from the programmer 24 to the implant 10.
The programmer 24 comprises, essentially, in addition to head 22, a housing or case 26 containing the telemetry system, namely the circuits for the emission/reception and processing of the telemetry signals, as well as an interface (I/f) 34 for a remote processing unit 28. Unit 28 is generally in the form of a microcomputer/personal computer that is connected to the case 26 by a cable. Data can be exchanged between the programmer 24 and the microcomputer unit 28 via a data bus, using, for example, the bus standard PCMCIA, which allows one to use for the microcomputer unit 28 any type of device having a port that conforms to this standard.
More preferably, the case 26 contains a circuit 30 for the reception of signals collected by the head 22 from the implant 10, and a system of circuits for analog processing of the signal, which provide, in a known manner, signal conditioning, namely the amplification, filtering, etc., of the collected signal (as described for example, in the aforementioned EP-A-0 661 077 and U.S. application Ser. No. 08/363,742). The circuit 30 thus delivers an output signal designated OUTPUT-SIGNAL to an analog to digital converter 32, that, in turn, delivers as an output a set of signal samples Sj, Samples Sj are then analyzed, using a FIFO memory 36, the role and functioning of which is described in more detail below, by processing circuit 38. Processing circuit 38 performs certain calculations and the programmable sequential control, and is advantageously realized in the form of a digital signal processor (hereinafter DSP 38). DSPs are indeed known for their ability to perform easily calculations while knowing how to address peripheral devices, all the while under the control of a suitable control program.
The filling of the FIFO memory 36 is preferably sequenced by a control circuit 40, and the reading of FIFO memory 36 can be realized in an asynchronous manner by DSP 38.
The control program for DSP 38 can be contained in a typical memory device, e.g., ROM, PROM or RAM, FLASH, EEPROM, etc., (not shown) in a manner in itself known and therefore not described here.
Nevertheless, to provide the present invention with the flexibility of functioning and an evolution that is peculiar to systems controlled by a program, one can foresee to download the control program for DSP 38 from the microcomputer unit 28, with the memory storing the program for DSP 38 being then essentially a RAM-type memory, with simply a ROM containing a "boot" program for the start of the control of the downloading of the control program to the RAM from the microcomputer unit 28, as well as a fail-safe program to commute the implant to operation in a nominal mode if the commutation between the programmer 26 and the microcomputer unit 28 is defective, and therefore prevents proper downloading of the control program.
One such manner of proceeding allows the behavior of the device according to the invention to evolve over time, for example, to adapt the programmer system (comprising head 22, case 26 and microcomputer unit 28) to implants of types not yet defined, without modifying the programmer system other than the installation of a new version of the control program in the microcomputer unit 28. The downloading of the control program thus allows one to install modifications without any change of the head 22 or the programmer case 26, simply by distributing an update diskette. This is desirable in contrast to the known techniques which, until now, have required the physical opening of the programming head and the change of a memory hardware component (EPROM). It should be understood that case 26 could be integrated into microcomputer unit 28 (or vice versa) when desired for cost, cosmetic or marketing reasons.
The programmer case 26 also contains a timing clock 42, which is controlled by an oscillator 44. In a characteristic manner of the invention, the clock 42 is a programmable type clock. As will be discussed below with reference to FIG. 6, clock 42 has an output frequency pulse train 142 (a so-called the "digitizing clock signal") which is synchronized by a timing clock frequency pulse train 128, and the frequency of clock pulses 142 is a whole multiple of the frequency of clock pulses 128.
The programmer case 26 contains also an emission circuit 46, also driven by the clock pulses 128 (FIG. 6), and which operates under the control of DSP 38. This emission circuit thus provokes the passage of oscillating currents to a coil contained in the head 22 in a manner to insure the transmission of information from the programmer to the implant. One can thus establish a bi-directional communication between implant 10 and programmer 24. The order and the type of messages exchanged between the implant 10 and the programmer 24, in one direction or the other, can be determined by the use of higher level software programming, as may be appropriately selected, by the microcomputer unit 28, whose instructions are read, via an interface 34, by the calculation and control functions of DSP 38. In particular, it is from the microcomputer unit 28 that the order to begin a bi-directional communication between programmer and implant will be sent. When this communication begins, and until it ends, messages will pass according to different steps, the entire set of which constitutes a "session". In order that the two systems could suitably cooperate, it is necessary to anticipate and provide a suitable communication protocol, defining the format and the direction of messages.
The essential characteristic of the present invention is to be able to operate a synchronous transmission between the programmer 24 and the implant 10. More specifically, the implant and the programmer each possess, as indicated, a timing clock, respectively clocks 18 and 42 (FIG. 2), serving as the base time, and whose frequency is typically 32,768 Hz (32 kHz). If the two clocks 18 and 42 are in phase, and their transitions serve as the origin of times for the dispatch and the reception of symbols (units of information) constituting messages in the telemetry signals, then the analysis of these symbols will be facilitated, in comparison with the case in which the programmer and the implant mutually ignore the state of their base times.
In addition to achieving a maximal reliability in the decoding of symbols, one also will be able to operate the transmission at a higher cadence (transmission rate), thereby allowing to reduce the duration of the transmission and/or to transmit a greater volume of data. The latter is particularly of interest when the autonomous device (implanted or not) records data over a very long period (e.g., in the case of typical Holter recordings (with or without data compression)).
FIG. 2 illustrates the interest of the synchronism between the transmitter system and the receiver system for a correct decoding of the emitted symbols. The transmitter sends to the receiver a message 100 having a plurality of symbols 102, 104, . . . 114, . . . , and the task of the receiver is to receive, analyze and recognize successive symbols so as to decipher correctly the message.
If one designates a time TD as the time necessary for the transmitter to emit a given symbol, and if the receiver analyzes the message during a duration TD to which it is not synchronized, the analysis may well focus on parts of two successive symbols, as illustrated by the different "cross-hatchings" of signal 116 on the second line of the time-diagram of FIG. 2. On the other hand, if the receiver is in synchronism with the transmitter, the analysis will focus on a single symbol, as illustrated by the uniform "cross-hatchings" of signal 118 on the third line of the time-diagram of FIG. 2. Only a correct synchronization allows one to use correctly the duration TD to analyze the message. This will be further explained with reference to FIG. 3.
Suppose that an "alphabet" (that is, a system of symbols susceptible to be transmitted in a telemetry signal transmission) is an alphabet with two symbols 120 and 122 as illustrated in curves (a) and (b) on FIG. 3, in units of amplitude (S) versus time (t). If the analysis begins at the same time as the appearance of the symbol, the recognition of the symbol will be possible. On the other hand, for an identical analysis time, but badly localized relative in time to a given symbol, the result of an analysis will be a symbol not belonging to the alphabet, as illustrated in curve (c) on FIG. 3, where one has represented a "message" 124 comprising part of a symbol 122 followed by part of a symbol 120 (nonsynchronized). If one analyzes this message 124 during a duration TD that is delayed in relation to the beginning of the symbol 120 (nonsynchronized), one obtains the message 124 that is not a valid symbol belonging to the alphabet.
When one operates a nonsynchronous transmission, one has, in a manner in itself known, to operate the analysis on a duration greater than TD, which therefore requires an increase in the time between symbols (inter-symbol time) and its associated costs, as compared to a situation where there is synchronism. The lack of synchronism also often results in an increase in the processing means calculations and a loss in the speed of transmission.
If TD is the time between symbols, and N is the number of symbols in the alphabet, the transmission rate, in bits/second will be:
D=(1/T.sub.D) log.sub.2 (N).
One is going now to describe the principle of obtaining synchronism as implemented by the present invention, with reference to FIG. 4.
In FIG. 4, timing line (a) represents an emitted message 132 from the implant (I) to the programmer (P), timing line (b) represents an emitted message 130 from the programmer P to the implant I, timing line (c) represents clock timing pulses emitted by the implant H(I), and timing line (d) represents clock timing pulses of the programmer H(P), these two clocks each operating at a fixed frequency F0. Given the two clocks establishing the timing of messages, one has then F0 =1/TD.
If one considers the programmer and the implant before there has been an exchange of data between them, their clocks have no phase relationship between them.
To establish a phase relationship, the programmer emits a request message 130 (interrogation signal) to the implant, this request being conceived so as to be comprehensible by the implant without first requiring any synchronism. In response to this request message 130, the implant replies by emitting a message 132 which is timed by the frequency of the implant clock H(I) pulses 126. The message 132, which is hereafter called the "synchronization signal", will be advantageously constituted by the repetition of the same symbol, this symbol being one that can be generated by realizing in the implant the excitation of a coil by an appropriate control means (which is not illustrated because it is a known technique), which excitation will produce an electrical current, and therefore a magnetic induction. The magnetic induction is collected by the programmer; after processing, the useful signal (that is, the voltages in the coil of the programmer) appearing at the input of the converter 32 (FIG. 1) will have a form that corresponds typically to that illustrated in dotted lines 134 on FIG. 7. The duration TS to S of this signal corresponds advantageously to a frequency FS =1/TS equal to 128 kHz. The SIGNAL-OUTPUT is advantageously analyzed by DSP 38 after digitization by the converter 32, which provides a digital value Sj, advantageously of 8 bits. The signal Sj, before being analyzed by DSP 38, is advantageously stored in a FIFO memory 36, that, as one knows, provides accessibility in an asynchronous manner for simultaneously reading and writing. The mode of access to FIFO 36 is illustrated with reference to FIG. 5. If, in the course of an analysis window, that is during duration TD, DSP 38 analyzes P samples of the signal Sj, it is then possible to let, in the course a phase 136, the FIFO memory fill with P values, captured at regular intervals according to a judicious timing realized by means of control circuit 40 controlling the write signal for FIFO memory 36. At the next analysis window, DSP 38 can then begin by reading, during a phase 138, the P values contained in the FIFO memory 36, while FIFO 36 continues to fill, in the course of a subsequent phase 140, with P other values.
One understands that DSP 38 can thus read in a continuous phase the P samples Sj that it needs, and can then process them without interruption, avoiding thus complications of processing and loss of times inherent to a system that would not use a FIFO memory and in which, each arrival of a new value of signal, it would be necessary to provoke an interruption of the execution of operations in DSP 38 to be able to take into account this new value.
The programmer clock frequency pulse train clock 128 is produced by the division, by a number M, of the output frequency signal produced by the oscillator 44, that is, for example, a quartz oscillator at a frequency FOSC of 4,194,304 Hz (4 mHz). The division is realized by the circuit 42 that, controlled by DSP 38, possesses the ability to adjust (advance or delay) the phase of the clock signal delivered at the output (the clock thus being "programmable"). Rising edges of the clock pulses 128 thus serve as reference points or triggers for the circuit 40 that controls the converter 32.
FIG. 6 illustrates the manner in which control circuit 40 operates as a function of the clock pulses 128. The signal output by the oscillator 44 is divided by a number N so as to provide a signal 142 at a frequency Fe =FOSC /N, that one will call hereafter the "sampling frequency".
Furthermore, as noted, the frequency of clock pulses 128 is the result of the division of the oscillator 44 output signal by a number M. By choosing M and N such that there exists a number P realizing the equality M=P*N, one will have therefore P periods of the clock 142 during one period between clock pulses train 128, and then Fe=P/TD.
If the control circuit 40 produces a first transition from each clock pulse 142 to an instant distinct from the transition of the rising edge of each clock pulse 128, with a temporal difference θ, then the (P+1)th transition from the next clock pulse 142 will arrive at the instant θ+(P/Fe)=θ+TD, that is to say a time θ after the rising edge following from the clock pulse 128, that is then well locked in phase with the clock 142.
If one notes the number j of the transition of the clock pulse 142 after a raising edge of the clock pulse 128, and that the transitions from the clock 142 serve as the sampling signal to trigger the digitization of SIGNAL-OUTPUT by converter 32, one obtains at the output of converter 32 a series of signals Sj equal, within the digitization error limit, to the values of SIGNAL-OUTPUT at j instants.
To realize the synchronization, DSP 38 realizes first of all the operation of averaging of the signal over a number K of analysis window durations TD, i.e., during a duration TA =K*TD. One creates then a series of values <S>j defined by: ##EQU1## By operating on the signal of synchronization, where the symbol is repetitious, this operation aims solely to decrease the relative amplitude of the noise by a factor √K. The signal <S>j will have then the form already illustrated in the dotted line curve 134 on FIG. 7, to the limit of digitization. This curve 134 will be able to be judged to be resembling close enough a pattern Tj, illustrated in solid line curve 144 on FIG. 7, that the system will use for correlation with <S>j, according to the operation: ##EQU2## Tj designating the jth point of the pattern 144. Cl is then the lth point of the correlation function of <S> and T.
The equation above is separated in two sums, so as to keep indices on <S> comprised in the interval 0 . . . (P-1)!, which is equivalent to calculate the correlation of T with the continuation by periodicity of <S>, that one will designate <S >. Further, the more the pattern T is similar to <S >, the more the function K is similar to the auto-correlation function <S>*<S >.
One knows that the auto-correlation function <S >*<S >!l is maximal for l=0, and that the correlation function <Sn >j =<S >j+n is maximal for l=-n.
In others words, the position of the maximum 146 of the correlation function 148, illustrated in FIG. 8, between a function with limited support <S> and the translated function by its continuation by periodicity, indicates the magnitude of the transfer. It is this property that the present invention uses to realize the synchronization of clocks between the programmer and the implant, which is illustrated in FIGS. 7, 8 and 9. If the pattern Tj is advantageously chosen to present a strong resemblance with the digitized and averaged signal <S>j, then the correlation function Cl (curve 148 on FIG. 8) previously defined will have its maximum 146 (FIG. 8) placed at l=0 when Tj and <S>j are in coincidence, which corresponds to the configuration of FIGS. 7 and 8. FIG. 9 represents, in the temporal reference of the programmer, the suitable analysis made by the programmer for determining the difference of phase between programmer clock pulses 128 (FIG. 4) and implant clock pulses 126 (FIG. 4).
Referring to case (A) of FIG. 9, the implant clock pulses 126 present a phase delay as compared to that of the programmer, which delay one will designate the by magnitude n, the unit of time being the sampling period 1/Fe. Symbols constituting the synchronization symbol beginning at each new transition from the clock pulse of the implant, the set of points <S>j (jΣ 0 . . . (P-1)!) constituting the average of symbols of the synchronization symbol which will appear also delayed by n. The correlation function with Tj will present, therefore, its maximum at -n or P-n, if this correlation function, for the periodicity of period P which can be easily calculated, is analyzed over the interval 0 . . . (P-1)!.
In the case (B) of FIG. 9, the clock pulses 126 and 128 are in phase and the maximum of the correlation function with the reference pattern of <S>j is at l=0. If, opposite to case (A), the clock pulses 126 are advanced in phase as compared to the clock pulses 128, which corresponds to the case (C) of FIG. 9, the aforementioned maximum of the correlation function will be situated at l=+n (provided that the maximum is situated at l=-n in the case of a delay of phase). It allows, therefore, the DSP 38 to re-establish the equality of the phase between clock pulses 126 and 128 (FIG. 4), to determine, by calculating, the maximum of the correlation function Cl, and to impose on the programmable clock 42 a phase delay equal to the position of this maximum. One will note nevertheless that the preceding conclusions are strictly exact only if the frequencies of the clock pulses 126 and 128 are exactly the same, that is to say, if one has F0 =FOSC /M=1/TD.
If, on the contrary, there exists a slight difference in frequency, which in practice is always the case when two oscillators are independently constructed, then one can write FI =FP (1+Ε), where FI designates the frequency of the implant clock pulses 126 and FP the frequency of the programmer clock pulses 128. One knows that, if Ε<<1, then the difference in phase of a complete analysis window duration TD will reappear at the end of a time on the order TD /Ε, i.e., 1/Ε windows. If clock pulses 126 and 128 are, advantageously, produced by quartz oscillators, then Ε will be on the order 10-4. Thus, if the synchronization signal comprises 100 emissions of the same symbol, the difference in phase between the first and the last emission will be on the order 10-2 window durations TD and will be able to be neglected in the present application, where the period of sampling will be advantageously equal to 1/Fe =1/(32TD). In this case, the relative difference in phase between clock pulses 126 and 128 will be on the order of a third of this period after a complete synchronization phase.
Advantageously, in the present invention, messages exchanged from the programmer to the implant via telemetry signals, as well as from the implant to the programmer, are realized by group of sub-messages called "frames". Because of the energy supply available in the programmer, as compared to the active medical implant devices, the signal/noise ratio in the direction of the programmer to implant can be far greater than in the other direction, and the transmission from the programmer to the implant can be made by coding bits by the presence or the absence of a signal in a predetermined temporal window. If the programmer and the implant have been previously synchronized, the temporal window will be able to be reduced to the period Td of clocks 18 and 42, respectively of the implant and of the programmer, conferring thus the same speed in the direction of the programmer to implant as in the other direction, which constitutes an original characteristic of the invention and substantial improvement in relation to known systems, in which the transmission from implant to programmer is generally the most rapid.
Frames define instants where the delivery of symbols by the programmer and the implant are authorized, these frames being effective after synchronization between the two devices is established. FIG. 10 presents the manner in which the exchanges of data are realized in accordance with this placement of frames. The case (A) of FIG. 10 corresponds to a frame 150 in the course of which messages go mainly from the implant to the programmer, the case (B) corresponds to a frame 152 in the course of which messages go mainly in the other direction. The duration of each frame is designated by Tf and will be, as well as each duration playing a role in the frames, a multiple of the analysis window duration TD in the programmer and in the implant. Before the frame signal 150 begins, one waits for the preceding framework to be ended. The programmer is then inactive and the implant is in a mode of reception 154.
When the frame begins, in a manner imposed by the programmer, which will be a master in relation to the implant, a heading 156 is emitted by the programmer. This heading 156 contains information indicating to the implant that the implant has then to emit information to the programmer. The heading is, for example, formed by a signal of duration TH =4TD transporting four bits and presenting a common structure in all cases (that is, in frames 150 as well as 152), with a frame beginning bit (bit `1`, corresponding to an emission always present in a coding in "all or nothing") followed by three bits of message (as clarified below). If the frame 152 is a frame "programmer to implant", after a eventual duration of rest time TR, the programmer emits signals in the field 158, of duration TE, that the implant receives and interprets. During the emission of this field 158 by the programmer, the implant is then in a state of reception in field 160, of duration TB. After the end of this field 160, the implant returns to a state of reception in field 162, in wait of a new heading of a frame. The bits are advantageously emitted in the field 158 by the presence or the absence of a signal, and similarly in the heading 156 (coding in "all or nothing"), the absence of signal received by the implant, in the field 162, will cease to be interpreted as a datum.
If the frame is of the type "implant to programmer" (frame 150), then the implant, after an eventual rest time duration TR, is going to emit a message to the programmer, in the field 164. The programmer then decodes the message in the field 166 of the frame.
The last three bits of the heading (the aforementioned message bits) can serve to control exchanges between the programmer and the implant, especially to remedy transmission errors detected by the system. These bits can advantageously have the following meanings:
`111` (I to P): the implant is going to emit a synchronization frame;
`100` (I to P): the implant is going to send data to the programmer;
`010` (P to I): the programmer is going to send data to the implant;
`001` (P to I): pause;
`000` (P to I): end of session;
`110` (I to P): the implant is going to return the same field of data as in the preceding frame;
`100` (P to I): the implant does not take in account the latest frames it receives and will take in account the data that follows;
`011`: no significance.
One will note that the message `111`, which asks the implant to emit a synchronization frame, is coded in manner to be understood by the implant without synchronization having been already established. Indeed, the detection by the implant of signals sent by the programmer being made by detection or not of the presence of these signals during the analysis window duration TD, the detection of a synchronization request frame is equivalent to detect the presence of a signal, for example, during a plurality of successive analysis windows (typically, four successive analysis windows). Indeed, if these signals succeed with a period less than or equal to a fraction of TD, regardless of the state of synchronism between implant and programmer clocks pulses 126 and 128, the implant will see the presence of a signal at the output of its reception circuits during at least four (in the considered example) of these temporal analysis windows and will interpret the presence of these repeated signals as a heading comprising the message `111`, which will release from it the delivery of a synchronization frame.
It will be understood that symbols can be suitably decoded only if the programmer and the implant have been previously synchronized, this decoding being operated by evaluating at a particular instant .0. the correlation function. But, during the transmission of a frame 150, a fraction of the temporal window corresponds to a delay of de-synchronization that appears at the end of a frame. As one has seen above, with clocks controlled by quartz oscillators, the number of temporal windows can be on the order a hundred before the de-synchronization becomes too large. If FI is the frequency of the implant clock pulses 126 and FP is the frequency of the programmer clock pulses 128, and these frequencies are linked by FI =FP (1+Ε), with Ε<<1, and that a frame has a duration of K windows, then at the end of the duration, the de-synchronization is on the order KΕTD, where TD is the duration of a temporal analysis window.
If the correlation function between a symbol and the reference pattern serving to detect the symbol is maximal at the time .0. at the beginning of a frame, it will be offset by KΕTD as compared to its reference window reference at the end of this frame. Consequently, if one observes the correlation function in a window having width 2KΕTD centered at .0., the maximum of this function will belong to the window in question. More precisely, at the jth observed cell (an observation time corresponding to TD), the difference of the correlation function will be Δj =jΕTD. If DSP 38 undertakes the operation: ##EQU3## one will the have Σ.sub.Δ = K(K-1)/2!ΕTD and, if K is large Σ.sub.Δ =K2 /2)ΕTD. The delay KΕTD at the end of frame is therefore linked to Σ.sub.Δ by the relationship KΕTD =(2/K)Σ.sub.Δ.
One will understand that, if one determines the correlation function maximum in a window of width 2KΕTD at each window, and if one averages the instants of maxima, one obtains then a quantity that allows to know the difference of phase at the end of a frame. This difference of phase is then introduced in the programmable clock 42 so as to operate a re-synchronization, which allows, in a characteristic manner of the invention, to proceed to the re-synchronization during transmission. One will have also noted that, if messages are transmitted to the implant in a type frame 152 (FIG. 10), it will be necessary to insert a type frame 150 in the transmission, because it is during these frames that the programmer will have the possibility to re-synchronize on the implant.
It should be understood that the references to the clock frequencies, clock pulses and clock signals are to be considered as synonyms in that it is the period and a particular point in a period from which the phased delay can be interpreted, e.g., the rising edge of a pulse in a pulse train, and not the particular shape or form of the clock output signal.
One skilled in the art will appreciate that the present invention can be practical by other than the described embodiments, which are presented for purposes of explanation and not of limitation.